JPS6241600B2 - - Google Patents

Info

Publication number
JPS6241600B2
JPS6241600B2 JP55044358A JP4435880A JPS6241600B2 JP S6241600 B2 JPS6241600 B2 JP S6241600B2 JP 55044358 A JP55044358 A JP 55044358A JP 4435880 A JP4435880 A JP 4435880A JP S6241600 B2 JPS6241600 B2 JP S6241600B2
Authority
JP
Japan
Prior art keywords
group
mercaptopropanoyl
hydroxyphenyl
acetyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55044358A
Other languages
English (en)
Japanese (ja)
Other versions
JPS56139455A (en
Inventor
Junichi Iwao
Masayuki Ooya
Tadashi Iso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Priority to JP4435880A priority Critical patent/JPS56139455A/ja
Priority to AT81900940T priority patent/ATE16396T1/de
Priority to DE8181900940T priority patent/DE3172803D1/de
Priority to PCT/JP1981/000074 priority patent/WO1981002893A1/ja
Priority to EP81900940A priority patent/EP0048763B1/en
Priority to US06/314,064 priority patent/US4425333A/en
Publication of JPS56139455A publication Critical patent/JPS56139455A/ja
Publication of JPS6241600B2 publication Critical patent/JPS6241600B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP4435880A 1980-04-02 1980-04-02 Sulfur-containing acylaminoacid Granted JPS56139455A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP4435880A JPS56139455A (en) 1980-04-02 1980-04-02 Sulfur-containing acylaminoacid
AT81900940T ATE16396T1 (de) 1980-04-02 1981-04-02 Schwefel enthaltende acylaminosaeuren.
DE8181900940T DE3172803D1 (en) 1980-04-02 1981-04-02 Sulfur-containing acylamino acids
PCT/JP1981/000074 WO1981002893A1 (fr) 1980-04-02 1981-04-02 Acylamino acides contenant du soufre
EP81900940A EP0048763B1 (en) 1980-04-02 1981-04-02 Sulfur-containing acylamino acids
US06/314,064 US4425333A (en) 1980-04-02 1981-04-02 Sulfur-containing acylamino acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4435880A JPS56139455A (en) 1980-04-02 1980-04-02 Sulfur-containing acylaminoacid

Publications (2)

Publication Number Publication Date
JPS56139455A JPS56139455A (en) 1981-10-30
JPS6241600B2 true JPS6241600B2 (enExample) 1987-09-03

Family

ID=12689281

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4435880A Granted JPS56139455A (en) 1980-04-02 1980-04-02 Sulfur-containing acylaminoacid

Country Status (4)

Country Link
US (1) US4425333A (enExample)
EP (1) EP0048763B1 (enExample)
JP (1) JPS56139455A (enExample)
WO (1) WO1981002893A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5683483A (en) * 1979-12-13 1981-07-08 Santen Pharmaceut Co Ltd Thiazolidine compound
JPS57112381A (en) * 1980-12-29 1982-07-13 Santen Pharmaceut Co Ltd Five-membered heterocyclic compound
US4596819A (en) * 1984-01-23 1986-06-24 Warner-Lambert Company Modified tripeptides
JPS6188884A (ja) * 1984-10-04 1986-05-07 Sankyo Co Ltd エンケフアリナ−ゼｂ阻害物質およびその製法
US4636522A (en) * 1985-03-22 1987-01-13 E. R. Squibb & Sons, Inc. Acylaminoalkanoyl urethanes or thiourethanes
DE3818850A1 (de) * 1988-06-03 1989-12-07 Hoechst Ag Oligopeptide mit zyklischen prolin-analogen aminosaeuren
JP2973271B2 (ja) * 1994-01-18 1999-11-08 参天製薬株式会社 エンドペプチダーゼ２４．１５阻害剤
JP2002501518A (ja) * 1997-05-30 2002-01-15 セルテック セラピューティックス リミテッド 抗炎症性チロシン誘導体
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
US6197794B1 (en) * 1998-01-08 2001-03-06 Celltech Therapeutics Limited Phenylalanine derivatives
US6329372B1 (en) 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
ES2226413T3 (es) 1998-02-26 2005-03-16 Celltech Therapeutics Limited Derivados de fenilalanina como inhibidores de alfa-4 integrinas.
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
GB9811969D0 (en) 1998-06-03 1998-07-29 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
WO2000006594A1 (en) * 1998-07-28 2000-02-10 Santen Pharmaceutical Co., Ltd. Novel thiazolidine derivatives
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9821222D0 (en) 1998-09-30 1998-11-25 Celltech Therapeutics Ltd Chemical compounds
GB9825652D0 (en) 1998-11-23 1999-01-13 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6534513B1 (en) 1999-09-29 2003-03-18 Celltech R&D Limited Phenylalkanoic acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
DE60130910T2 (de) 2000-04-17 2008-07-10 Ucb Pharma, S.A. Enamin-derivate als zell-adhäsionsmoleküle
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
US6740654B2 (en) 2000-07-07 2004-05-25 Celltech R & D Limited Squaric acid derivatives
AU2001275724A1 (en) 2000-08-02 2002-02-13 Celltech R&D Limited 3-substituted isoquinolin-1-yl derivatives
KR100778708B1 (ko) * 2006-06-30 2007-11-22 주식회사 대우일렉트로닉스 진공청소기용 모터보호장치

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046889A (en) 1976-02-13 1977-09-06 E. R. Squibb & Sons, Inc. Azetidine-2-carboxylic acid derivatives
AU518147B2 (en) * 1976-12-03 1981-09-17 E.R. Squibb & Sons, Inc. Derivatives of thiazolidine, thiazine and morpholine carboxylic acids
US4192878A (en) 1976-12-03 1980-03-11 E. R. Squibb & Sons, Inc. Derivatives of thiazolidinecarboxylic acids and related acids
IT1105731B (it) * 1977-06-29 1985-11-04 Yoshitomi Pharmaceutical Composti di tiazolidina
US4283407A (en) * 1977-09-28 1981-08-11 Science Union Et Cie Thiopropionamides, and the pharmaceutical compositions
JPS5455565A (en) * 1977-10-06 1979-05-02 Santen Pharmaceut Co Ltd Novel thiazolidine derivative
FR2412537A1 (fr) * 1977-12-22 1979-07-20 Science Union & Cie Nouveaux thiobutyramides substitues, leurs procedes d'obtention et leur application pharmaceutique
JPS54100369A (en) * 1978-01-21 1979-08-08 Santen Pharmaceutical Co Ltd Thiazolidine derivative
AU528115B2 (en) 1978-04-08 1983-04-14 Santen Pharmaceutical Co. Ltd. Antihypertensive 4-thiazolidine/carboxylic acids
US4282235A (en) 1978-05-22 1981-08-04 E. R. Squibb & Sons, Inc. Derivatives of thiazolidinecarboxylic acids and related acids
JPS54154763A (en) * 1978-05-25 1979-12-06 Yoshitomi Pharmaceut Ind Ltd Thiazolidine derivative
JPS559058A (en) * 1978-07-06 1980-01-22 Dainippon Pharmaceut Co Ltd 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivative
JPS559060A (en) * 1978-07-07 1980-01-22 Yoshitomi Pharmaceut Ind Ltd Thia(oxa)zolidinecarboxylic acid derivative and its prepatation
JPS5511547A (en) * 1978-07-11 1980-01-26 Santen Pharmaceut Co Ltd Thiazolidine derivative
AU537592B2 (en) 1979-04-02 1984-07-05 E.R. Squibb & Sons, Inc. Mercaptoacyldipeptides
JPS5522673A (en) * 1979-07-18 1980-02-18 Yoshitomi Pharmaceut Ind Ltd Thiazolidinecarboxylic acid derivative
US4283328A (en) 1979-10-01 1981-08-11 Research Corporation Preparation of dehydropeptides

Also Published As

Publication number Publication date
EP0048763B1 (en) 1985-11-06
EP0048763A4 (en) 1982-07-06
WO1981002893A1 (fr) 1981-10-15
EP0048763A1 (en) 1982-04-07
JPS56139455A (en) 1981-10-30
US4425333A (en) 1984-01-10

Similar Documents

Publication Publication Date Title
JPS6241600B2 (enExample)
US4748160A (en) Angiotensin converting enzyme inhibitors and their formulation and use as pharmaceuticals
CA1288547C (en) 1-(3-mercapto-2-methylpropanoyl) prolyl amino acid derivatives and salts thereof, processes for their preparation and pharmaceutical compositions containing such compounds
JP2973271B2 (ja) エンドペプチダーゼ２４．１５阻害剤
JPS584711B2 (ja) ピロリジン誘導体
JPH0587504B2 (enExample)
NO854516L (no) Nye 5-amino-4-hydroksyvalerylderivater.
JPH02161A (ja) アミノ酸から誘導される新規な光学異性体と、その製造方法と、その医薬への応用
US4707490A (en) Anti-hypertensive agents
JPH03386B2 (enExample)
US4500467A (en) Benzoylthio compounds, their preparation and their use as drugs
US5268361A (en) Hydroxyazido derivatives and related compounds as renin inhibitors
CA1247085A (en) Process for preparing n-carboxyalkylproline- containing tripeptides
JPH0448800B2 (enExample)
US4456594A (en) N-Carboxyalkylproline-containing tripeptides
JPH0135824B2 (enExample)
JPS6141356B2 (enExample)
JPH08325290A (ja) 新規メルカプトアルカノイルジペプチド化合物、その製造方法及びそれらを含む医薬組成物
JPS6141355B2 (enExample)
JPH0532602A (ja) ナフチルメチルアミン誘導体及びこれを含有するレニン阻害剤
JPS6141357B2 (enExample)
JPH06234630A (ja) 中性メタロエンドペプチダーゼ阻害剤
JPS59137451A (ja) インダン誘導体
EP0137746A2 (en) Nitrogen substituted angiotensin converting enzyme inhibitors
JPS648622B2 (enExample)